From: Hyponatremia and aging-related diseases: key player or innocent bystander? A systematic review
Study | Risk (95% CI) | p-value |
---|---|---|
Gankam Kengne et al. (2008) [10] | OR 4.16 (2.24–7.71) |  < 0.001 |
Sandhu et al. (2009) [36] | Not reported | 0.01 |
Kinsella et al. (2010) [19] | OR 2.25 (1.24–4.09) | 0.01 |
Chow et al. (2011) [37] | OR 1.44 (0.77–2.71) | 0.26 |
Hoorn et al. (2011) [4] | HR 1.34 (1.08–1.68) | 0.009 |
Tolouian et al. (2012) [38] | OR 4.80 (1.06–21.67) | 0.04 |
Arampatzis et al. (2013) [39] | OR 1.46 (1.05–2.04) | 0.03 |
Hagino et al. (2013) [40] | Not reported | 0.398 |
Afshinnia et al. (2015) [41] | Not reported |  ≤ 0.015 |
Ganguli et al. (2015) [29] | Not reported | 0.5513 (initial hyponatremia) |
0.1246 (persistent hyponatremia) | ||
Holm et al. (2015) [42] | HR 1.996 (1.096–3.529) | 0.022 |
Jamal et al. (2015) [43] | HR 1.67 (1.02–2.69) | Not reported |
Kruse et al. (2015) [20] | OR 1.516 (0.971–2.37) | 0.067 |
Usala et al. (2015) [44] | Not reported | Not reported |
Ayus et al. (2016) [45] | Not reported | Not reported |
Hosseini et al. (2018) [34] | OR 0.96 (0.71–1.31) | 0.83 |
Adams et al. (2019) [46] | RR 1.11 (1.09–1.13) | Not reported |
Nigwekar et al. (2019) [47] | OR 1.08 (0.89–1.30) in single episode hyponatremia, OR 2.65 (2.18–3.22) in chronic prolonged hyponatremia | Not reported |
Schiara et al. (2020) [21] | OR 2.56 (2.08–3.13) in hyponatremic respect to OA controls, OR 0.92 (0.83–1.02) in hyponatremic respect to AMI controls | Not reported |